PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-1.14
Both companies show losses. Martin Whitman would check if industry conditions create special situations.
No Data
No Data available this quarter, please select a different quarter.
0.49
P/B 50-75% of CRN.AX's 0.74. Bruce Berkowitz would examine if asset composition explains the gap.
-1.48
Negative FCF while CRN.AX shows P/FCF of 50.98. Joel Greenblatt would examine cash flow improvement potential.
-9.20
Negative operating cash flow while CRN.AX shows P/OCF of 12.69. Joel Greenblatt would examine operational improvement potential.
0.49
Fair value ratio 50-75% of CRN.AX's 0.74. Bruce Berkowitz would examine if business quality explains the gap.
-21.84%
Both companies show losses. Martin Whitman would check for industry-wide issues.
-67.44%
Negative FCF while CRN.AX shows yield of 1.96%. Joel Greenblatt would examine cash flow improvement potential.